Renal cell carcinoma (RCC) is the most common type of kidney cancer in adults. When cancer that began in the kidney spreads to distant parts of the body, it is described as metastatic renal cell carcinoma.
Metastatic disease is often classified as stage 4 kidney cancer, although staging and treatment decisions depend on the individual's cancer characteristics.
Cancer cells from the kidney can spread to areas such as:
-
Lungs
-
Bones
-
Liver
-
Brain
-
Distant lymph nodes
-
Other organs
A diagnosis of metastatic RCC can be overwhelming, but treatment options have changed considerably over the years.
Modern management may involve immunotherapy, targeted therapy, surgery in selected situations, radiation treatment for particular metastases, or combinations of these approaches.
The appropriate treatment depends on the cancer subtype, extent of spread, symptoms, overall health, previous treatment and other factors.
At Prabhakar Bhurke Clinic, Dr. Sandip Prabhakar Bhurke, super specialist nephrologist and transplant physician, provides specialist kidney care and can help patients with complex renal conditions coordinate appropriate multidisciplinary evaluation when kidney cancer affects renal function.
How Is Metastatic Kidney Cancer Different From Localized RCC?
The distinction between localized and metastatic kidney cancer is important because it influences treatment goals.
Localized Renal Cell Carcinoma
The cancer remains within the kidney or nearby tissues and has not spread to distant organs.
Surgery may be the main treatment in appropriate patients.
Metastatic Renal Cell Carcinoma
The cancer has spread beyond the original kidney to distant organs or tissues.
Treatment generally focuses on controlling cancer throughout the body.
Systemic treatments are therefore particularly important in metastatic RCC.
In selected patients, surgery or local treatment of metastatic sites may also have a role.
What Are the Goals of Metastatic Renal Cell Carcinoma Treatment?
Treatment goals vary from person to person.
They may include:
-
Controlling cancer growth
-
Shrinking tumors
-
Delaying disease progression
-
Relieving cancer-related symptoms
-
Preserving organ function
-
Maintaining quality of life
-
Extending survival
-
Managing complications
For some patients, long-term disease control may be possible with modern systemic therapy.
Treatment decisions are individualized rather than based solely on the stage number.
How Is Metastatic RCC Confirmed?
Before choosing treatment, doctors need to understand how extensive the cancer is.
Evaluation may involve several investigations.
Imaging
Depending on the clinical situation, imaging can include:
-
CT scans
-
MRI
-
Ultrasound
-
Bone imaging
-
Brain imaging when clinically indicated
Imaging helps determine where the cancer has spread and how extensive the disease is.
Tissue Diagnosis
A biopsy may be recommended in selected cases to confirm the cancer type or obtain information that influences treatment.
Not every kidney mass requires biopsy, and the decision depends on the clinical situation.
Blood Tests
Blood testing can help assess:
-
Kidney function
-
Liver function
-
Blood counts
-
Electrolytes
-
Overall health
These results can influence treatment selection and help doctors monitor therapy.
What Types of Metastatic Renal Cell Carcinoma Exist?
Clear cell RCC is the most common subtype.
Other kidney cancer subtypes include:
-
Papillary RCC
-
Chromophobe RCC
-
Other less common renal tumor types
The pathological subtype can influence treatment decisions.
This is one reason why treatment should be planned by a multidisciplinary cancer team familiar with renal cell carcinoma.
Immunotherapy for Metastatic Renal Cell Carcinoma
Immunotherapy has become an important part of modern treatment for many patients with advanced clear cell RCC.
Instead of directly attacking cancer cells like traditional chemotherapy, immunotherapy helps the immune system recognize and respond to cancer.
Immune checkpoint inhibitors are among the treatments used in advanced RCC.
Depending on the patient's situation, treatment may involve:
-
An immune checkpoint inhibitor combination
-
Immunotherapy combined with targeted therapy
-
Other systemic treatment approaches
The specific regimen depends on cancer subtype, risk classification, previous treatment and overall health.
What Are Immune Checkpoint Inhibitors?
Cancer can sometimes interfere with immune responses that would otherwise help recognize abnormal cells.
Checkpoint inhibitor medicines can block certain immune-regulating pathways and help restore anti-tumor immune activity.
Examples of immune pathways targeted in cancer treatment include:
-
PD-1
-
PD-L1
-
CTLA-4
Not every patient responds to every immunotherapy.
Treatment selection is made by the oncology team based on the patient's disease characteristics and current treatment guidelines.
Targeted Therapy for Metastatic RCC
Targeted medicines act on biological pathways that help cancer cells survive, grow or develop a blood supply.
Several targeted therapies have been used in advanced renal cell carcinoma.
Treatment may target pathways involving:
-
VEGF
-
Tyrosine kinases
-
mTOR
-
Other molecular signaling mechanisms
Some targeted medicines are administered as tablets, although treatment schedules differ between medicines.
The choice depends on the cancer type, previous treatment, side-effect profile and individual patient factors.
Why Does RCC Respond to Anti-Angiogenic Treatment?
Renal cell carcinoma can depend on signals that promote the growth of blood vessels supplying the tumor.
This process is known as angiogenesis.
Certain targeted therapies interfere with these pathways.
By reducing signaling involved in tumor blood-vessel formation and cancer growth, these medicines can slow disease progression in appropriate patients.
Is Chemotherapy Used for Metastatic Renal Cell Carcinoma?
Traditional chemotherapy is generally not the main treatment for most clear cell renal cell carcinomas.
This is different from some other cancers where chemotherapy plays a central role.
Advanced RCC treatment more commonly relies on immunotherapy and targeted therapy.
However, treatment depends on the exact tumor subtype, and some uncommon renal cancers may behave differently.
Therefore, the pathology report is important when planning treatment.
Does Surgery Have a Role in Metastatic RCC?
Surgery may still be considered in selected patients with metastatic disease.
Historically, removal of the affected kidney, called cytoreductive nephrectomy, was used more routinely in metastatic RCC.
Today, the role and timing of kidney surgery are more selective.
Surgery may be considered depending on:
-
Overall health
-
Cancer burden
-
Symptoms
-
Tumor characteristics
-
Response to systemic treatment
-
Number and location of metastases
-
Whether complete or meaningful disease control is achievable
Removing the primary kidney tumor is not automatically appropriate for every patient with metastatic disease.
Can Metastatic Tumors Be Surgically Removed?
Sometimes.
If cancer has spread to a limited number of sites, local treatment may be considered in carefully selected patients.
Possible approaches can include:
-
Surgery
-
Ablation
-
Radiation therapy
-
Stereotactic radiation in selected situations
The decision depends on the location and number of metastases and the patient's overall disease status.
Radiation Therapy in Metastatic Kidney Cancer
Radiation is not usually the primary treatment for all metastatic RCC.
However, it can be valuable for selected problems.
For example, radiation may help manage:
-
Painful bone metastases
-
Brain metastases
-
Certain areas at risk of complications
-
Selected oligometastatic disease
Modern radiation techniques can allow focused treatment of specific metastatic sites when appropriate.
What If Kidney Cancer Spreads to the Bones?
Bone metastases can cause:
-
Bone pain
-
Fractures
-
Reduced mobility
-
High calcium levels
-
Spinal cord compression in serious cases
Treatment may involve a combination of:
-
Systemic cancer therapy
-
Radiation
-
Surgery in selected cases
-
Bone-directed medicines
-
Pain management
-
Orthopedic or neurosurgical assessment when necessary
Severe new back pain, weakness or loss of bladder or bowel control requires urgent medical assessment because spinal cord compression can be an emergency.
What If RCC Spreads to the Brain?
Brain metastases require prompt specialist assessment.
Depending on the number, size and location of lesions, treatment may include:
-
Surgery
-
Stereotactic radiation
-
Whole-brain radiation in selected circumstances
-
Systemic therapy
-
Supportive treatment
The treatment plan is determined by a multidisciplinary team.
How Is Treatment Chosen for Metastatic RCC?
Doctors consider more than the cancer stage.
Important factors may include:
-
RCC subtype
-
Tumor burden
-
Sites of metastasis
-
Symptoms
-
Previous treatment
-
General health
-
Kidney function
-
Liver function
-
Blood counts
-
Performance status
-
Risk classification
-
Patient preferences
This allows the treatment plan to be tailored to the individual.
Why Kidney Function Matters During Cancer Treatment
The kidneys can be affected by the cancer itself, previous surgery, dehydration, obstruction, medications or other medical conditions.
Kidney function is therefore important when planning and monitoring cancer treatment.
Doctors may regularly assess:
-
Serum creatinine
-
eGFR
-
Electrolytes
-
Urine findings
-
Blood pressure
-
Fluid status
Maintaining adequate kidney function can be particularly important when the patient has one functioning kidney or pre-existing kidney disease.
Can Metastatic RCC Cause Kidney-Related Symptoms?
Some patients have symptoms caused by the primary kidney tumor or metastatic disease.
Possible symptoms include:
-
Blood in urine
-
Flank discomfort
-
Abdominal mass or discomfort
-
Unexplained weight loss
-
Fatigue
-
Fever without an obvious infection
-
Loss of appetite
However, metastatic RCC may also be discovered during imaging performed for another reason.
Symptoms alone cannot determine whether kidney cancer is present.
What Side Effects Can Cancer Treatment Cause?
Side effects vary considerably depending on the medicine or combination used.
Immunotherapy Side Effects
Immune-related adverse effects can affect different organs.
Possible problems include inflammation involving:
-
Skin
-
Thyroid
-
Liver
-
Colon
-
Lungs
-
Kidneys
-
Other organs
Prompt reporting of new symptoms is important because some immune-related adverse effects require treatment interruption or specific medical therapy.
Targeted Therapy Side Effects
Depending on the medicine, possible adverse effects can include:
-
Fatigue
-
Diarrhea
-
High blood pressure
-
Hand-foot skin reactions
-
Mouth sores
-
Changes in thyroid function
-
Appetite changes
-
Liver abnormalities
The exact side-effect profile varies by medication.
Can Metastatic Renal Cell Carcinoma Be Cured?
A complete cure is not possible for every patient with metastatic RCC.
However, treatment can sometimes achieve substantial and prolonged control of the disease.
Some patients may experience significant tumor shrinkage or long periods without disease progression.
Treatment outcomes vary widely according to:
-
Cancer biology
-
Extent of disease
-
Response to therapy
-
General health
-
Treatment options available
It is therefore not appropriate to predict an individual's outcome from the stage alone.
What Happens If the First Treatment Stops Working?
Metastatic RCC can sometimes develop resistance to treatment.
If the cancer progresses, the oncology team may consider another treatment strategy.
Options can include:
-
Changing targeted therapy
-
Switching systemic treatment
-
Another immunotherapy-based approach when appropriate
-
Combination therapy
-
Clinical trials
-
Local treatment for selected metastatic sites
The next treatment depends on what the patient has already received and how the cancer has responded.
Can Clinical Trials Help?
Clinical trials are an important part of advancing treatment for metastatic kidney cancer.
Trials may investigate:
-
New immunotherapies
-
Novel targeted medicines
-
New drug combinations
-
Biomarker-guided treatment
-
New approaches to resistant disease
Eligibility varies between studies.
Patients interested in clinical trials can discuss available options with their oncology team.
Nutrition During Metastatic RCC Treatment
Good nutrition can help patients maintain strength during cancer treatment.
However, there is no single diet that cures metastatic kidney cancer.
Dietary recommendations may need to consider:
-
Kidney function
-
Appetite
-
Weight changes
-
Treatment side effects
-
Diabetes
-
Blood pressure
-
Electrolyte levels
Patients with reduced kidney function may need individualized advice regarding sodium, protein, potassium, phosphorus and fluid intake.
Avoid extreme diets or unverified cancer supplements.
Should Patients Take Herbal Remedies During Cancer Treatment?
Patients should be cautious with herbal medicines and supplements.
Some products can:
-
Interact with cancer medicines
-
Affect liver or kidney function
-
Alter drug metabolism
-
Increase bleeding risk
-
Delay evidence-based treatment
Always tell the treating oncology and nephrology teams about supplements or alternative medicines being used.
Can Metastatic RCC Affect the Remaining Kidney?
If one kidney has been removed or is severely affected, the remaining kidney becomes particularly important.
Kidney-protective care may include:
-
Monitoring eGFR
-
Controlling blood pressure
-
Avoiding unnecessary kidney-harming medicines
-
Managing diabetes
-
Maintaining appropriate hydration
-
Monitoring urine protein when appropriate
-
Reviewing medications regularly
This is especially important when cancer treatment is being given alongside pre-existing kidney disease.
When Should a Patient Contact the Doctor Urgently?
During metastatic kidney cancer treatment, urgent medical assessment may be required for:
-
Severe breathlessness
-
Chest pain
-
New confusion
-
Severe dehydration
-
Very little or no urine
-
Severe bleeding
-
Persistent high fever
-
Severe abdominal or flank pain
-
New weakness or paralysis
-
Severe headache with neurological symptoms
Patients receiving immunotherapy should also promptly report significant new symptoms because immune-related complications can sometimes progress rapidly.
Why Multidisciplinary Care Matters
Metastatic RCC can involve multiple organs and may affect kidney function, nutrition, pain, mobility and other aspects of health.
Care may therefore involve:
-
Medical oncologists
-
Urologists
-
Nephrologists
-
Transplant physicians
-
Radiation oncologists
-
Radiologists
-
Pathologists
-
Palliative-care specialists
-
Other healthcare professionals
A coordinated approach can help balance cancer treatment with preservation of kidney and overall health.
Metastatic Kidney Cancer and Kidney Care at Prabhakar Bhurke Clinic
At Prabhakar Bhurke Clinic, Dr. Sandip Prabhakar Bhurke, super specialist nephrologist and transplant physician, provides specialist kidney evaluation for patients with complex renal conditions, including those whose kidney function may require careful monitoring during cancer care.
Depending on the patient's circumstances, nephrology support may include:
-
Assessment of baseline kidney function
-
Creatinine and eGFR monitoring
-
Blood-pressure management
-
Evaluation of protein in urine
-
Medication review
-
Assessment of kidney complications
-
Management of acute kidney injury
-
Kidney-function monitoring during complex medical treatment
-
Coordination with oncology and urology teams when appropriate
-
Kidney care after major renal surgery
Cancer treatment itself should be planned by an appropriately qualified oncology team. Nephrology care can complement cancer management when kidney function is an important consideration.
Frequently Asked Questions
What is the best treatment for metastatic renal cell carcinoma?
There is no single treatment that is best for every patient. Modern management commonly involves immunotherapy, targeted therapy or combinations, with surgery or radiation considered in selected circumstances.
Is metastatic renal cell carcinoma the same as stage 4 kidney cancer?
Metastatic RCC generally corresponds to stage 4 disease because the cancer has spread to distant sites. The exact staging and treatment plan depend on the individual's cancer findings.
Can metastatic kidney cancer be cured?
Not every case can be cured, but modern treatments can sometimes produce significant and prolonged disease control. Outcomes vary substantially between patients.
Is chemotherapy effective for metastatic renal cell carcinoma?
Traditional chemotherapy is generally not the main treatment for most clear cell RCC. Immunotherapy and targeted therapies are more commonly used for advanced disease, although treatment varies by tumor subtype.
Does immunotherapy work for kidney cancer?
Immunotherapy can be an effective treatment for many patients with advanced RCC. Response varies, and the appropriate regimen depends on the patient's cancer characteristics and previous treatments.
Can surgery help in metastatic kidney cancer?
Surgery may benefit selected patients, but removing the kidney is not automatically recommended for everyone with metastatic RCC. The decision depends on overall health, tumor burden, symptoms, metastatic sites and systemic treatment considerations.
What happens if metastatic RCC progresses after treatment?
The oncology team can reassess the disease and consider another systemic treatment, a different targeted medicine, immunotherapy-based treatment, local therapy or a clinical trial when appropriate.
Why is kidney function monitored during metastatic RCC treatment?
Kidney function can influence treatment decisions and may be affected by the cancer, surgery, dehydration, medicines or other complications. Monitoring creatinine, eGFR and related tests can help identify kidney problems early.
Conclusion
Metastatic renal cell carcinoma treatment has evolved significantly, with immunotherapy and targeted therapies providing important options for many patients with advanced kidney cancer.
Treatment is no longer based simply on removing the kidney or using traditional chemotherapy. Depending on the cancer subtype and individual circumstances, management may involve systemic immunotherapy, targeted medicines, surgery, radiation, combinations of treatments or clinical-trial options.
The appropriate strategy depends on the extent of metastasis, tumor biology, previous treatment, symptoms, general health and kidney function.
Because advanced kidney cancer can require care from several specialties, coordination between oncology, urology and nephrology teams can be particularly valuable when kidney function is compromised or complex renal issues are present.
For specialist kidney-function assessment and nephrology care, Prabhakar Bhurke Clinic provides individualized care under Dr. Sandip Prabhakar Bhurke, super specialist nephrologist and transplant physician.
Medical Disclaimer
This article is intended for general educational and informational purposes only and does not constitute medical advice, diagnosis or treatment. Metastatic renal cell carcinoma is a serious condition requiring individualized evaluation by an appropriately qualified cancer care team. Treatment options vary according to cancer subtype, stage, metastatic sites, molecular and pathological findings, previous treatment, kidney function and overall health. Immunotherapy, targeted therapy, surgery and radiation can have significant risks and side effects and are not suitable for every patient. Information about medicines and treatment approaches in this article should not be used to start, stop or change cancer treatment. Patients should discuss diagnosis and treatment options with their oncologist, urologist and other appropriate specialists. Severe breathlessness, chest pain, confusion, very little or no urine, severe bleeding, persistent high fever, new neurological symptoms or rapidly worsening health require urgent medical attention.
